kw.\*:("Dexméthylphénidate")
Results 1 to 11 of 11
Selection :
Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical TrialLOWER, Elyse E; FLEISHMAN, Stewart; COOPER, Alyse et al.Journal of pain and symptom management. 2009, Vol 38, Num 5, pp 650-662, issn 0885-3924, 13 p.Article
Dexmethylphenidate Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity DisorderSILVA, Raul R; MUNIZ, Rafael; PESTREICH, Linda et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2008, Vol 47, Num 2, pp 199-208, issn 0890-8567, 10 p.Article
Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorderGREENHILL, Laurence L; MUNIZ, Rafael; BALL, Roberta R et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2006, Vol 45, Num 7, pp 817-823, issn 0890-8567, 7 p.Article
Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorderSPENCER, Thomas J; ADLER, Lenard A; MCGOUGH, James J et al.Biological psychiatry (1969). 2007, Vol 61, Num 12, pp 1380-1387, issn 0006-3223, 8 p.Article
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d, l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorderWIGAL, Sharon; SWANSON, James M; FEIFEL, David et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2004, Vol 43, Num 11, pp 1406-1414, issn 0890-8567, 9 p.Article
Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorderSUGRUE, David; BOGNER, Robin; EHRET, Megan J et al.American journal of health-system pharmacy. 2014, Vol 71, Num 14, pp 1163-1170, issn 1079-2082, 8 p.Article
Dexmethylphenidate extended release : In attention-deficit hyperactivity disorder. CommentaryROBINSON, Dean M; KEATING, Gillian M; PATRICK, Kennerly S et al.Drugs (Basel). 2006, Vol 66, Num 5, pp 661-670, issn 0012-6667, 10 p.Article
Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in AdultsSANTOSH, Paramala J; SATTAR, Sanjida; CANAGARATNAM, Myooran et al.CNS drugs. 2011, Vol 25, Num 9, pp 737-763, issn 1172-7047, 27 p.Article
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in AdolescentsCHILDRESS, Ann C; BERRY, Sally A.Drugs (Basel). 2012, Vol 72, Num 3, pp 309-325, issn 0012-6667, 17 p.Article
Dexmethylphenidate. CommentariesKEATING, Gillian M; FIGGITT, David P; STEIN, Mark A et al.Drugs (Basel). 2002, Vol 62, Num 13, pp 1899-1908, issn 0012-6667, 10 p.Article
Neurobehavioral effects of racemic threo-methylphenidate and its D and L enantiomers in ratsTEO, Steve K; STIRLING, David I; THOMAS, Steve D et al.Pharmacology, biochemistry and behavior. 2003, Vol 74, Num 3, pp 747-754, issn 0091-3057, 8 p.Article